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ABSTRACT When silica nanoparticles (SiNP) are stored in aqueous solution, even for few hours, 
they have a tendency to form agglomerates and therefore adapt inhomogeneous structures. Here 
we present a very practical method to store SiNP in responsive hydrogel. We have confirmed that 
SiNP kept in the responsive hydrogel do not undergo through undesirable morphological changes 
and while in storage they maintain their excellent colloidal stability. The effect of SiNP hollowing 
(i.e. dissolution of the core of the particles that leaves empty cavity inside) was significantly 
inhibited in the hydrogel, which is a critical feature for any nano-medical applications (e.g. 
controlled drug release). To demonstrate the applicability of the hydrogel-storing concept within 
a biologically relevant context, in this work we have evaluated the toxicological effects of the 
responsive SiNP-gel formulation in a model in vitro (human cell line U87GM and 
hemocompatibility using red blood cells) and ex ovo (henÕs egg test) experiments. Particles stored 
in the gel as well as the pure gel did not affect the hemocompatibility (hemolysis and erythrocyte 
aggregation) up to a concentration of 100 µg/mL. Furthermore, systemic injections into the blood 
circulation of the chick area vasculosa confirmed the biocompatibility in a more complex 
biological environment. All evaluated toxicological values (haemorrhage, thrombosis, vascular 
lysis, and lethality) were comparable with the negative control and no differences in toxicological 
response could be observed between the SiNP stored in hydrogel and the control nanoparticles 
stored in the solution.  
INTRODUCTION 
Functionalized silica nanoparticles (SiNP) are very popular models used in variety of 
applications and studies ranging from biomedical sensors (Burns et al., 2006, Gubala et al., 2011, 
Gubala et al., 2010), drug delivery (Ma et al., 2012) and in vivo imaging (Ma et al., 2015) among 
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others. However, their widespread use in commercial products, particularly in nanomedicine, still 
has not reach the potential that was promised in so many published papers (Venditto et al., 2013). 
One significant problem that has not been fully addressed so far is the tendency of silica to 
agglomerate into largely polydispersed clusters or grow (also known as to ÔripenÕ) into large 
individual particles when they are stored in aqueous solutions (Orts-Gil et al., 2011, Provis et al., 
2006). For such reasons, scientists tend to work with Ôfreshly madeÕ nanoparticles that are not yet 
agglomerated. This represents a particularly prominent challenge in nanomedical applications, 
because it is impractical or very often impossible to prepare fresh batch of nanoparticles just before 
they are to be investigated or used. In addition, the core and/or the surface of SiNP is often 
physically or chemically altered (e.g. encapsulation of dyes or drugs inside a core-matrix and/or 
modification of nanoparticle surface with more biocompatible material). The resulting functional 
SiNP are usually stored for a long time before they are used in the desired biological applications 
(Nel et al., 2009, Wang et al., 2014). It is not a trivial task to ensure the as-prepared, functionalized 
SiNP do not undergo through any undesired morphological changes that would affect their 
toxicity, probability of collision with the target cells, cellular uptake mechanism and retain their 
intended physico-chemical properties, homogeneous size distribution and function while in 
storage. Common methods used to stabilize nanoparticles in solution (sterically or 
electrostatically) include post-synthetic surface modification with polymers such as dextran 
(Moore et al., 2015), polyethylene glycol (Emoto et al., 1998, Graf et al., 2012, Ruiz et al., 2013, 
Wang et al., 2015), lipids (Snchez-Moreno et al., 2015, Zaloga et al., 2015) or by other complex 
surface chemistry (Fang et al., 2009). Although many of these methods could be sophisticated and 
elegant, some may still have limits in scalability and practicality. The most common remaining 
problems are: i) the inadequate stability of silica nanoparticles in buffered, cell culture media 
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(MacCuspie et al., 2011) and ii) undesired changes in the particle functionality when coated with 
bulky polymers (Zaloga et al., 2015).  
We have previously attempted to improve the colloidal stability of functionalized SiNP by 
storing them as freeze-dried powders (Moore et al., 2015) but the lyophilisation technique required 
the use of cryoprotectants, which could be expensive and it could potentially alter the NPÕs 
morphology (Kho et al., 2010). More recently, we have reported on a versatile, practical and 
straightforward approach to store the SiNP in a responsive hydrogel (Giovannini et al., 2017). The 
SiNP-gel concept is very simple: i) a solution of a highly effective hydrogelator, Fmoc-
galactosamine (Fmoc-Gal) is added to nanoparticles; ii) the solution/suspension solidifies into self-
supporting hydrogel, thus restricting any undesired phenomena such as particle sedimentation, 
undesired particle-particle interactions accelerated by Brownian motion (Petersson et al., 2006) 
and/or effects related to Ostwald ripening of silica nanoparticles (Provis et al., 2006); iii) SiNP are 
stored in hydrogel for a long time; and iv) when needed, the SiNP-gel formulation is simply shaken 
by hand, which turns the self-supporting gel into suspension of nanoparticles. Such reconstituted 
nanoparticles would have the same physico-chemical properties as Ôfreshly madeÕ nanoparticles. 
The concept is animated here: https://www.youtube.com/watch?v=EUQns52Q_q4&feature=em-
share_video_user.  
Such reconstituted SiNP can be used with minimal user manipulation in the desired application. 
However, when the SiNP-gel formulation was reconstituted into a solution, we noticed the 
presence of nano-sized gel fibers in the solution. It is therefore critical to understand if the presence 
of the fibers in the reconstituted SiNP-gel formulation can alter the biocompatibility of the 
nanomaterial. In this work, we studied the efficiency and applicability of the SiNP-gel formulation 
in model in vitro and ex ovo systems. Firstly, transmission electron microscopy (TEM) and 
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dynamic light scattering (DLS) were used to track the changes in morphology and size distribution 
of the dextran-coated SiNP (SiNP-Dex) upon longer term storage and when diluted in complex 
biological media, e.g. cell culture. Secondly, in vitro toxicological studies were conducted on the 
human cell line U87GM (glioblastoma astrocytoma) and hemocompatibility tests on red blood 
cells were performed to determine whether the SiNP-Dex-gel formulation can induce hemolysis 
or aggregation of red blood cells when compared with the simple suspension of particles (SiNP-
Dex-sol). Additionally, an ex ovo test system was used to assess the hemorrhage, thrombosis, 
vascular lysis and embryonic lethality close to the situation in vivo when SiNP-Dex in gel, gel only 
and SiNP-Dex in solution were injected into the vitelline vein of the chick area vasculosa. All in 
vitro and ex ovo assays proved that the proposed gel-storage method is effective in stabilizing silica 
nanoparticles for long term and the presence of gel or gel debris do not alter the biocompatibility 
of the nanoparticles. The proposed method is scalable, practical and it can directly be used in 
biological application without the need for laborious purification steps. Furthermore, we showed 
that SiNP formulated in gel maintain their morphology even after reconstitution and dilution in 




Cyclohexane (anhydrous, 99.5%), 1-hexanol (anhydrous, ≥99%), Triton¨ X-100, 3-
(Trihydroxysilyl)propyl methylphosphonate, monosodium salt 50 wt % in water (THPMP), (3-
aminopropyl)trimethoxysilane [APTMS] (97%), tetraethyl orthosilicate [TEOS] (99,99%), 
ammonium hydroxide solution (28% w/v in water, ≥99.99%), Fluorescein isothiocyante, 
Rhodamine B isothiocyanate, dextran from Leuconostoc spp. Mr ~ 40.000, sodium borohydride 
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(> 99.9%), sodium periodate (> 99.8%), dimethylformamide (DMF) were purchased from Sigma 
Aldrich. Absolute ethanol, phosphate buffer saline tablets (one tablet dissolved in 200 mL DI water 
yields 0.01 M phosphate buffer, pH 7.4) were purchased from Fisher Scientific. Hereafter, the use 
of ÔPBSÕ refers to 0.01 M PBS, pH 7.4. Deionised water was prepared using 200 nm nylon 
membrane filters purchased from Millipore. DulcebboÕs Modified Eagle Medium (DMEM) 
without phenol red and pyruvate and a high level of D-Glucose, DMEM with phenol red, 
antibiotic-antimycotic (containing 10,000 units/mL of penicillin, 10,000 μg/mL of stremptomycin 
and 25 μg/mL of FungizoneTM) and fetal bovine serum (FBS) were purchased from GibicoTM 
(Life Technologies). Human glioblastoma cell line (GBM) U87-MG (ATCC¨ HTB-14ª, grade 
IV WHO classification) was obtained from American Type Culture Collection (ATCC¨, 
Manassas, VA, USA). CellTiter 96¨ Aqueous One solution cell proliferation assay MTS was 
purchased from Promega. 
 
Synthetic procedures 
SiNP were synthesized according to a well-established reverse-microemulsion method (Bagwe 
et al., 2004). This procedure yields monodisperse spherical nanoparticles and enables effective 
encapsulation of fluorescent dyes (Bae et al., 2012). 
Synthesis of SiNP Ð Rhodamine doped nanoparticles 
In a dried glass vial, 2 mg of Rhodamine B isothiocyanate (RITC) was dissolved in 2 mL of 1-
hexanol and APTMS (5.6 µL) was added. After mixing, the reaction was allowed to proceed for 2 
hours under a dinitrogen atmosphere after which time the dye precursor (RITC-conjugated 
APTMS) was formed.  
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SiNP were formed in a microemulsion prepared by combining cyclohehexane (7.5 mL), 1-
hexanol (1.133 mL), Triton¨ X-100 (1.894 g), DI water (0.48 mL) in a 30 mL plastic bottle under 
constant stirring. To this mixture, 100 µL of TEOS was added followed by 0.666 mL dye precursor 
solution. After 30 min, 40 µL of ammonium hydroxide was added to trigger polymerization. After 
24 h stirring, 50 µL of TEOS was added to the microemulsion, followed, after 30 min, by the 
addition of 40 µL of THPMP whit 5 minute as interval 10 µL of ATPMS. The mixture was stirred 
for a further 24 h. After that, the microemulsion was broken by adding 30 mL ethanol. The formed 
SiNP were purified by centrifugation (14000 rpm, 10 min) and re-dispersion in 30 mL ethanol (3 
times). After purification, the nanoparticles were stored in ethanol at 4¡C.  
Synthesis of SiNP Ð fluorescein doped nanoparticles 
Fluorescein loaded SiNP have been synthesized following the same procedure presented above 
using 2.5 mg of Fluorescein isothiocyante (FITC) instead of RITC for the formation of the dye 
precursor. The solution of FITC-conjugated APTMS was then added to the microemulsion system 
during the SiNP synthesis as described above.  
Synthesis of SiNP-Dex Ð Dextran coating 
1 µg of 40 kDa dextran was dissolved in 10 mM solution of sodium periodate (0.5 ml) in water 
at room temperature. After 1.5 hours, the solution was used to re-disperse a pellet of 1 mg of SiNP 
and the suspension was shaken for 1 hour. 0.5 ml of 10 mM solution of sodium borohydride in 
DMF was added to the suspension and shaken for another 30 minutes. The samples were then 
centrifuged (1400 rpm, 10 min) to isolate the particles from the solution and the pellet was washed 
once with water. The dextran-coated particles were redispersed in water and the suspension was 
immediately used to prepare both the solution and the gel sample as described in the following 
paragraph. 
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SiNP-Dex-gel Ð Preparation of Nanoparticle-loaded Gels 
For a typical nanoparticle-gel preparation, 2 mg/mL solutions of Fmoc-Gal [18] were prepared. 
The gelator was dissolved in filtered DI water via mechanical stirring at 30¡C. Meanwhile, 0.5 mg 
of nanoparticles was isolated from the water suspension by centrifugation. The pellet was then re-
dispersed in 1 mL of gel solution by ultra-sonication for 20 s using the Sonics vibracell probe at 
20% amplitude. This sonication step secured the SiNPÕs maximum monodispersity and also 
triggered gel formation, which normally occurred in next few minutes. The formation of self-
supporting gel could be observed by the naked eye and was confirmed simply by inverting the vial.   
SiNP-Dex-sol Ð Preparation of aqueous SiNP-Dex solutions 
Aqueous solutions of SiNP-Dex were prepared following the procedure for NP-Gel samples, but 
with the omission of Fmoc-Gal. 
 
Characterization 
Dynamic light scattering 
DLS experiments were performed on the instrument NanoZS ZEN3600 from Malvern Zetasizer 
with the operating wavelength 633 nm and folded capillary cell (DTS1060) was used with the 
instrument. All NanoparticlesÕ dispersions in DI water or DMEM were typically analyzed at 
concentrations 0.5 mg/mL and at room temperature. Dispersion Technology Software (Zetasizer 
Nanoseries) was used for the analysis of the data. The default parameter for the water based NP 
solution were: refractive index: 1.333; viscosity: 0.8872 cP, dielectric constant: 79.5. All values 
are reported as average of three measurements (n=3) ± SD. 
Transmission electron microscopy 
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TEM micrographs were obtained using a Joel JEM-3200FS transmission electron microscope. 
Sample preparation involved carefully pipetting the solution of the NP-gel and NP-solution 
samples in water (approximately 5 µL) onto ÔCarbon Films on 400 Mesh Grids CopperÕ from Agar 
Scientific. Images were recorded at 250, 200 or 120 kV (accelerating voltage). 
Analysis 
Processing of Nanoparticle-gels and Nanoparticle-solutions 
Prior the TEM and DLS analysis (for nanoparticle samples stored in gels for a specific period of 
time), the gel was converted to liquid by shaking the sample by hand. The sample was then diluted 
with water reaching concentration 0.5 mg/mL NPs with total volume of 2 mL. When desired, 
different concentrations of NPs could be prepared by further dilutions. Solution-stored 
nanoparticle samples were processed in an identical way to the gel samples.   
Analysis of SiNP-Dex-gel and SiNP-Dex-sol diluted in DMEM 
Four solution samples and four gel samples of SiNP-Dex were prepared following the procedure 
mentioned above. After one week of storage, both solution and gel samples were vortexed at 
maximum speed for 10 s to break the gel matrix, in the case of the gel-samples, and the samples 
were analyzed with TEM and DLS. All samples were diluted with 1 ml of DMEM. These samples 
were analyzed after 2, 4, 6 and 8 hours, respectively, using DLS, TEM and by tracking their flow 




The human cell line GBM cell line U87-MG (ATCC¨ HTB-14ª, grade IV WHO classification) 
was cultured in monolayer in a flask. U87MG cells were maintained in DMEM supplemented with 
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FBS 10%, antibiotic 1% and sodium pyruvate 1%. Cells were kept at 37¡C in a humidified 
atmosphere containing 5 % CO2. To evaluate the toxicity of SiNP stored in solution and in gel, 
cells were seeded into 96-well plate at a density of 8000 cells/well and allowed to adhere for 24 
hours. SiNP samples were then diluted to appropriate concentrations with medium and 
immediately applied to the cells from which the old medium was removed. A preliminary study to 
determine the influence of the incubation time was accomplished. Cells were incubated for 
different times (2, 4, 8 and 12 hours) with 50 μg/mL of each sample. Once the incubation time was 
defined, the cells viability was evaluated treating cells with different concentrations of samples. 
SiNP concentrations of 100, 50 and 25 µg/mL, respectively, were incubated with cells for 2 hours 
to evaluate the dose/survival conditions. After incubation, the samples were carefully removed 
from the wells and 100 μL of fresh medium were added and, after addition of 20 μL of MTS 
reagent, the plate was incubated for another two hours. Healthy cells produce metabolic enzymes 
that modify MTS reagent. The product adsorbs at 490 nm therefore the intensity of the signal 
measured at this wavelength indicates cell viability. The latter experiment has been accomplished 
in triplicates. Untreated cells were used as control and the value measured represented the 100% 
of cell viability. The absorbance at 490 nm of SiNP-Dex-sol SiNP-Dex-gel and gel alone in 
absence of cells were used as blank.  
In vitro hemocompatibility test  
To predict the hemocompatibility of the synthesized particles, the hemolytic activity and the 
aggregation of erythrocytes were determined using in vitro red blood cell (RBC) assays according 
to Bauer et al. (Bauer et al., 2012). Briefly, heparinized sheep blood samples were purified and 
washed several times by centrifugation (2800×g, 7 min, 3 times) to remove the plasma and to 
collect the red blood cells. The washing steps were performed with an isotonic 5% glucose solution 
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buffered with 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (GlcHEPES) adjusted 
to pH 7.4.  
To analyze the red blood cell aggregation after interaction with the samples, the red blood cell 
stock solution was adjusted to 20.000 erythrocytes/µL in GlcHEPES solution. The dextran coated 
SiNP (either RITC- or FITC-labeled) in gel or solution as well as the gel (pure) were stored in a 
stock solution of 1 mg/mL and diluted with DI water to the test concentrations. Samples were 
pipetted in a 96well-plate and mixed with the red blood cells to the final concentrations 3.125, 
6.25, 12.5, 25, 50 and 100 µg/mL. Gel samples were liquefied using a vortex and diluted 
afterwards. The mixture of erythrocytes and samples was incubated for 2 h at 37¡C in an incubator 
(WTC Binder Tttlingen, Germany) under continuous shaking (1350 rpm). After incubation, the 
plates were analyzed by light microscopy (Primovert, Carl Zeiss, Jena, Germany) and by 
spectrophotometric measurements at 645 nm (Tecan Spark 10 M, Crailsheim, Germany) to 
quantify the RBC aggregation. As positive control a poly(ethylene imine) coated nanoparticle 
(fluidMAG-PEI 750/O, chemicell GmbH, Berlin, Germany, 160 µg/mL) was used, since this type 
of particle was proven to cause significant aggregations due to its positive surface charge(Schlenk 
et al., 2017). The negative control (GlcHEPES with erythrocytes), the blank (GlcHEPES without 
erythrocytes) and the sample controls (samples without erythrocytes) were used in each 
experiment. To quantify the erythrocyte aggregation, ΔAbs was calculated from the absorbance at 
645 nm using the following equation according to Schlenk et al.(Schlenk et al., 2017):  
ΔAbs = &���∗+,−./0+	23∗.435 −	���75−∗89 − (���;−<=5+ −	���;−<=5+	23∗.435)   (1) 
Light emitted through the RBCs in suspension is scattered by the erythrocytes. Non-aggregating 
samples are characterized by a lower amount of light reaching the detector (increased absorption). 
Therefore, test solutions with considerably lower absorbance values compared to the negative 
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control were regarded as RBC aggregation and resulted in increased ΔAbs values. Qualitative 
evaluation of aggregation by light microscopy was grouped into 3 stages: At stage 1 no aggregation 
was detectable and all erythrocytes stayed discrete in suspension; stage 2 indicated moderate 
aggregation with rouleaux formation, but the majority of the erythrocytes were still discrete in 
suspension; in stage 3 almost all erythrocytes were aggregated to big clusters and no free cells 
remained discrete in suspension. 
The hemolytic activity of the samples was analyzed by the quantification of the released 
hemoglobin by spectrophotometric measurement. The red blood cell stock solution was adjusted 
to 1.800.000 cells/µL and mixed (1:1) with the samples to the final test concentrations 3.125, 6.25, 
12.5, 25, 50 and 100 µg/mL. After 60 min incubation at 37 ¡C under continuous shaking 
(450 rpm), the red blood cells were removed by centrifugation at 2250!g (Eppendorf Centrifuge 
5804R, Eppendorf AG, Hamburg, Germany) and the supernatant was spectrophotometrically 
quantified at 544 nm. Blank values were determined measuring only the GlcHEPES solution 
without cells. Particle test samples diluted with GlcHEPES were tested in similar concentrations 
without erythrocytes (sample control) in order to exclude any influence on the absorption 
measurement. Cells treated with 1% solution of the nonionic surfactant Triton X-100 (Ferak Berlin 
GmbH, Berlin, Germany) was used as positive control. Untreated cells served as negative control. 





	× 100   (2) 
According to the ASTM F756-00 standard, the hemolytic activity of the samples was classified as 
0-2% non-hemolytic, 2-5% slightly hemolytic or >5% for hemolytic activity. Experiments were 
run in triplicates and performed with dextran coated particles (either RITC or FITC labelled 
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particles with similar size and surface potential) stored in solution or gel as well as with the pure 
gel. Data of the RBC aggregation and hemolysis assay are represented as mean ± SD.  
 
Ex ovo henÕs egg test on chick area vasculosa (HET-CAV) 
To investigate the effect of the particles in a dynamic complex biological test system, we used a 
shell less henÕs egg test on the chick area vasculosa (HET-CAV) according to Schlenk et al. 
(Schlenk et al., 2017). Briefly, fertilized eggs were incubated for 72 h at 37 ¡C. After incubation, 
eggs were transferred into petri dishes (Greiner Bio-One GmbH, Frickenhausen, Germany) 
containing RingerÕs solution pH 7.0 and incubated for further 24 h. For the experiments only eggs 
with a well-developed chick area vasculosa according to Hamburger and Hamilton stages 14-17 
were selected (Hamburger et al., 1951). Test samples (SiNP-Dex-sol, SiNP-Dex-gel and gel alone) 
were stored in a stock solution of 1 mg/mL and diluted to the test concentration (50 or 125 µg/mL) 
with DI water. The gel samples were liquefied by mechanical shaking using a vortex and diluted 
equally to the final test concentrations. A volume of 2 µL of each sample was injected into the 
upper or lower vitelline vein of the embryos chick area vasculosa (CAV) using a micro injector 
(Sutter Instrument Company, Novato, USA). According to the recommendations of the 
Interagency Coordinating Committee on the Validation of Alternative Method (ICCVAM) for the 
HET-CAM test 0.9% sodium chloride was used as negative control. Since samples were diluted 
with DI water it was run as solvent control in each experiment. As a positive control a solution of 
branched poly(ethylene imine) (25 kDa, 25 mg/mL, kindly provided by BASF, Ludwigshafen, 
Germany) was used. Each sample was tested at least in two independent experiments with a 
minimum total number of 8 eggs. Eggs were analyzed after 0, 1, 2, 4, 8 and 24 h for thrombosis, 






RESULTS AND DISCUSSION 
NPs synthesis and storage-stability analysis by TEM and DLS 
Pristine SiNP loaded with Rhodamine B (for imaging purposes and to assess the possible ÔdrugÕ 
leaching effect) were prepared following a well-known reverse microemulsion protocol (Bagwe 
et al., 2004). Such SiNP usually displays a negative surface charge, which is imparted by the use 
of a mixture of organosilanes (THPMP:APTMS in 4:1 ratio v/v) to form an outer shell, usually 
few nanometres thick. According to DLS analysis, the average size of the SiNP was 157 nm 
(surface charge -32.4 mV), while the same sample by TEM analysis gave average size of 59 nm. 
This discrepancy in size is understandable as DLS allows to observe the full hydrodynamic radius 
of nanoparticles in their solvated state, whereas TEM measures the same sample in the dry state 
(i.e. the most compact state) (Cascio et al., 2014, Sokolov et al., 2015). The presence of ÐNH2 
groups on the surface of SiNP (from APTMS) allowed coating with polyaldehyde dextran (40kDa) 
using a procedure published in our group previously (Moore at al., 2015). The reaction is 
schematically depicted in Figure 1a. The reasons for dextran coating were two-fold: i) dextran is 
a well-known biocompatible polymer used to coat nanoparticles applied in the clinics (Peng et al., 
2015, Shaterabadi et al., 2017) and ii) dextran-coated SiNP can be readily functionalized with 
biomolecules such as antibodies to provide SiNP with cell-targeting capabilities (Tivnan et al., 
2012). The fact that dextran was successfully grafted onto the SiNP surface was evident from both 
the DLS and TEM data (Table 1) and is in agreement with previously published data (Moore et al. 
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2015). The size of SiNP-Dex was 160.2 by DLS and 63 nm by TEM. Importantly, the zeta 
potential, indicative of the overall surface charge of the measured colloid decreased from -32.4 to 
-25.1 mV, when compared with the pristine SiNP, suggesting a successful chemical reaction on 
the nanoparticle surface. 
Table 1 Comparison of size and polydispersity of the SiNP prepared by the microemulsion method 
measured by DLS and TEM in water at a concentration of 0.25 mg/mL. Measurements are reported 
as average values (n=3) ± SD.  
 DLS TEM 
 ¯ (nm) PDI ζ (mV) ¯ (nm) 
SiNP 157.0 ± 48.2 0.277 -32.4 ± 0.87  59 ± 16 
SiNP-Dex 160.2 ± 29.7 0.287 -25.1 ± 0.55 63 ± 11 
SiNP-Dex-sol (1week) 133.0 ± 42.3 0.238 -27.5 ± 1.84  109 ± 19 
SiNP-Dex-gel (1week) 126.1 ± 21.2 0.354 -11.5 ± 2.24  91 ± 28 
 
 
It is noteworthy to mention that DLS is a highly accurate technique when used with samples of 
narrow particle size distributions especially in the range of 2Ð500 nm (Tomaszewska et al., 2013). 
Polydispersed samples or any samples with additives that can potentially scatter light (e.g. the 
nano-sized gel fibres remaining in the solution after storage) can distort the results and limit the 
use of DLS to accurately assess the degree of SiNP agglomeration while in a solution and in a 
hydrogel. When the SiNP-gels were stored and then ÔconvertedÕ into a solution (by shaking), the 
DLS measurements provided inconclusive data because of the scattering contribution of the gel 
fibres present in the solution. Therefore, we have analysed the changes in morphology and the 
evolution of agglomerates or other higher ordered species for both SiNP stored in solution and in 
hydrogel (SiNP-Dex-sol and SiNP-Dex-gel respectively) by TEM. Unlike DLS technique, TEM 
allows for direct visualization of the nanoparticles even in the presence of other debris or 
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nanofibres, making it possible to identify the presence of different populations of particles and 
other entities in the sample.  
In the first experiment, one set of SiNP-Dex was stored in water (SiNP-Dex-sol) while another 
identical set of SiNP-Dex was stored in a hydrogel (SiNP-Dex-gel). After 7 days of storage at 4ѾC 
in the dark, both samples were analysed by TEM. The SiNP-Dex-sol sample was deposited directly 
on the TEM grid as removed from the refrigerator, the SiNP-Dex-gel sample was shaken by hand 
to ÔbreakÕ the hydrogel into a solution before deposited on the TEM grid. The images, shown on 
Figure 1c indicate that both nanoparticle samples were relatively stable although the diameter of 
the SiNP-Dex-sol was slightly higher when compared to SiNP-Dex-gel. Interestingly, upon careful 
analysis of the TEM images, we noticed the SiNP-Dex-sol hollowing, a phenomenon described 
previously in the literature (Gubala et al., 2010, Moore et al., 2017, Park et al., 2009, Rimer et al., 
2007). For example, Park et al., OÕConnell et al. and also Moore et al. reported on the degradation 
of silica NPs into hollowed spheres due to etching under basic, aqueous conditions (OÕConnell et 
al., 2017, Park et al., 2008). The dissolution and hollowing of silica matrix are highly unwelcome 
effects, especially when SiNP are designed as vehicles to be encapsulated with drugs as nano-drug 
delivery system or with contrast agents (e.g. fluorescence, MRI or luminescence) for in vivo 
imaging applications. Importantly, the nanoparticle degradation effect was negligible for SiNP-
Dex-gel after 1 week of storage as noticeable from the TEM images in Figure 1. Therefore, SiNP-
Dex-gel will presumably retain their cargo for much longer period of time when compared to the 




Figure 1 (a) schematic illustration of the SiNP surface composition and the reaction with 
polyaldehyde dextran to form SiNP-Dex; the inset shows the mechanism of Schiff base formation 
and subsequently stabilisation of the C-N bond by NaBH4 reduction (b) TEM images of the SiNP 
and (c) TEM images of the SiNP-Dex and also SiNP-Dex-sol and SiNP-Dex-gel after 1 week of 
storage at 4ûC in the dark. 
The hollowing effect was further probed qualitatively in a more complex biologically relevant 
medium. SiNP-Dex-sol and SiNP-Dex-gel were stored for 1 week and then diluted to 0.25 mg/mL 
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in Dulbecco's Modified Eagle's Medium (DMEM). We have previously reported on the challenges 
to maintain good colloidal stability of SiNP in enriched culture media (Moore et al. 2015). The 
hollowing/dissolution effect, the possible changes in the nanoparticle morphology and the degree 
of aggregation of nanoparticles were assessed by TEM for both SiNP-Dex-sol and SiNP-Dex-gel. 
Both solution and gel samples after storage were diluted with DMEM and placed at 4¡C for 8 
hours. This experiment was designed to reproduce a possible real-life scenario were SiNP were 
first synthesised, then stored and finally reconstituted to be used in a model biological experiment. 
After 2, 4, 6 and 8 hours in DMEM at 4¡C the samples were analysed by TEM (Figure 2). For both 
samples, the dissolution of the silica matrix is already partially evident after 2 hours. However, the 
hollowing effect, ÔbridgingÕ of individual particles and the evolution of the nanoparticles into 
larger agglomerates or even an undefined polymer matrix that would no longer fit to definition of 
nanoparticle is arguably accelerated with SiNP-Dex-sol. The SiNP-Dex-gel also experienced 
hollowing and dissolution but, after 8 hours in DMEM, it is still possible to recognize individual 






Figure 2 TEM images of SiNP-Dex-sol and SiNP-Dex-gel while incubated in DMEM for up to 8 
hours.  
In vitro microfluidic flow assessment 
Dye-doped SiNP and drug-encapsulated SiNP have been reported to play major roles either as 
bright labels in biomedical diagnostics (Bae et al., 2012) or as drug carriers in nano-drug delivery 
systems (NDDS) (Tivnan et al., 2012). The successful outcome in both applications depends 
strongly on the good colloidal stability and homogeneous distribution of the nanoparticles that are 
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usually placed in buffered solutions or more complex biological media, such as serum, plasma or 
whole blood. When SiNP are used in vivo as NDDS, agglomeration of SiNP is a highly undesired 
effect as it often leads to premature clearance of the material from the bloodstream and its 
accumulation in the liver or lungs(Ruiz et al., 2013). We have therefore designed a simple 
qualitative test to visually compare the degree of agglomeration between SiNP-Dex-sol and SiNP-
Dex-gel in a model microfluidic chip. Since the SiNP were labelled with a fluorescent dye 
(Rhodamine), it was possible to image the flow of the nanoparticles by epifluorescence microscopy 
(Axio Imaginer A1.m Zeiss, 10 x Objective, Filter set Ð 77HE from Zeiss, PCO camera). Both 
SiNP-Dex-sol and SiNP-Dex-gel were used in this test after 1 week of storage. The SiNP-Dex-gel 
were reconstituted into solution prior the injection into the microfluidic chip, which featured the 
zig-zag shaped microchannel (geometrical parameters of the channel: width = 150 µm, depth = 40 
µm). The two solutions (i.e. SiNP-Dex-sol and reconstituted SiNP-Dex-gel, both diluted in 
DMEM) were slowly pumped through this channel after 2, 4, 6 and 8 hours of the dilution with 
the medium while the fluorescence images were recorded (Figure 3). A short video was also 




Figure 3 Microscope images of SiNP-Dex-sol and SiNP-Dex-gel samples diluted in DMEM at 
different time point while they were flowing through the microfluidic chip. The particles were 
analyzed at concentration of 0.125 mg/mL and samples were pumped through the channel at a 
flow rate of 0.3 μL/s. More agglomerates were noticeable in SiNP-Dex-sol.  
It is important to mention that, due to the size of the original particles and the camera resolution, 
it was impossible to observe the individual nanoparticles. It was, however, possible to identify 
very clearly any agglomerates (the smallest fluorescent agglomerates detectable by this method 
were 4.5 µm in diameter). SiNP-Dex-gel, reconstituted in DMEM, showed the occasional 
agglomerate flowing through the channel within the 8 hours of being in a DMEM solution. This 
was in stark contrast with the solution of SiNP-Dex-sol in DMEM, which showed a significant 
number of visible objects (i.e. agglomerates or aggregates, not nano-sized anymore) flowing 
through the channel already at 4h. We have attempted to obtain more quantitative analysis of the 
degree of aggregation/agglomeration for each formulation. However, due to the nanoparticle 
hollowing effect over time and the associated dye leaching for SiNP-Dex-sol, we were only able 
to approximately quantify the colloidal stability of both SiNP-Dex-sol and SiNP-Dex-gel, 
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providing an indication of their behaviour while flowing in a microchannel. We have analyzed the 
fluorescent intensity values measured in the channel for each sample at 2, 4, 6 and 8 hoursÕ time 
points. Although this can only provide some quantitative indication of the nanoparticle 
agglomeration/aggregation, we observed between 1.7 Ð 3.4 times more agglomerates/aggregates 
in the SiNP-Dex-sol at every time point as compared to the SiNP-Dex-gel sample.  
 
Toxicological studies  
The hallmark of the presented SiNP storage method is the option of storing the nanomaterial inside 
a hydrogel, thus preserving its carefully designed properties and unique function. When needed, 
the particles can be brought back in suspension simply by shaking. After appropriate dilution, the 
sample can be used directly in any desired application. However, the reconstituted solution may 
contain fibre debris (i.e. higher-order assemblies created by the Fmoc-Gal hydrogelator). As shown 
in Figure 4, partial or complete dissolution of the Fmoc-gal fibres can be achieved by diluting the 
ÔbrokenÕ hydrogel sample. The complete dissolution of the gel fibres is also proportional to the 
amount of the aqueous medium (i.e. correlates with the dilution ratio) and it can be accelerated in 
solvents containing ethanol. 
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Figure 4 Dissolution of the gel fibres (blue scattering) of Fmoc-Gal (2 mg/mL) after 1/2; 1/10; 
and 1/100 dilutions in water and absolute ethanol. 
Because of the potential presence of the gel fibres, we addressed the need of proving that these 
residues in the SiNP-Dex-gel sample do not alter the effect of the nanomaterial when exposed to 
biological systems. We have designed simple in vitro and ex ovo assays in order to determine the 
effects of the gel and its components on the toxicity of SiNP-Dex.  
a)! MTS assay 
In the first instance, we obtained basic cytotoxicity data from an MTS assay performed with a 
human glioblastoma astrocytoma hematopoietic cell line (U87MG), mixed and incubated with 
three formulations: SiNP-Dex-gel, SiNP-Dex-sol and hydrogel without nanoparticles (all gels 
were reconstituted into solutions before the MTS assay). The U87MG cell line is known to be 
studied in experiments involving nanomaterials (Alkilany et al., 2010, Gianoncelli et al., 2013). 
The fact that they adhered to surfaces allowed us to remove the analysed sample after incubation, 
thus limiting any possible interferences between the particles/gel and the MTS reagent (tetrazolium 
salt). A preliminary experiment to determine the incubation time was performed, in which all 
samples at the concentration of 50 µg/mL were incubated with cells and the viability was tested 
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after 2, 4, 8 and 12 hours (data not showed). No relevant difference in cell viability was noticed 
between the different time-points, therefore 2 hours of incubation was used in the MTS 
experiments.  All formulations were incubated for 2 hours at different concentrations (100, 50 and 
25 µg/mL) with U87MG cells in a 96-well plate format in cell culture medium (in triplicate). Cells 
alone were used as a control and the absorbance measured after MTS reagent addition was 
regarded as 100% of cell viability. The MTS assay results are summarised in Figure 5A. After two 
hours of incubation, negligible cytotoxicity was detected with all studied samples at the lower 
concentrations, but a small drop in cell viability was observed at the high end of the concentration 
range for SiNP-Dex-gel or Gel alone.  
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Figure 5 MTS assay data on U87MG cell line: A) Cell viability as a function of different 
concentrations (100, 50 and 25 µg/mL) over the period of 2 hours. B) Evaluation of cell 
morphology during MTS assay. No relevant difference in the morphology of glioblastoma cells is 
noticeable. 
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In addition to the MTS assay, we have qualitatively investigated the cell morphology before and 
after incubation with all samples (Figure 5B). No significant changes in the cell morphology were 
observed, even when treated with the highest concentration of the nanomaterial. The cells appear 
spherical at lower degrees of confluence and more "star-like/branch out" at higher degrees of 
confluence. 
b) Hemocompatibility testing 
Blood is composed of a multitude of cell types, ranging from simple oxygen-carrying 
erythrocytes to sophisticated antigen-specific lymphocytes. The various cells participate in a vast 
array of functions, including tissue repair and immune responses as well as oxygen transport. After 
the systemic injection of the particles they can interact with blood components such as red blood 
cells (RBCs) as the major component of the blood cell pool possibly causes severe aggregation 
and hemolysis. Therefore, we tested the interactions of SiNP-Dex-sol and SiNP-Dex-gel as well 
as the pure gel (after the gel samples were liquefied) with isolated RBCs in vitro. In this 
experiment, samples of SiNPs with either a positively charged Rhodamine B isothiocyanate 
(RITC) or a negatively charged Fluorescein isothiocyanate (FITC) were prepared to provide an 
insight into the effect of the encapsulated material on the hemolysis. Hemolytic behavior would 
demonstrate a possible damage of the erythrocytes membrane accompanied by the release of 
hemoglobin that was measured by the absorbance of the RBC suspension and classified according 
to the ASTM F756-08 standard. As shown in Figure 6A, up to a concentration of 100 µg/mL, 
neither SiNP-Dex-sol, SiNP-Dex-gel (RITC or FITC doped) nor the gel (pure) showed hemolytic 
reactions (hemolysis < 2%) with the red blood cells in comparison to the positive control (1% 





Figure 6: Hemocompatibility testing: A) Different tested nanoparticle samples and gel showed no 
hemolysis (< 2%) in all tested concentrations up to 100 µg/mL; B) All tested samples showed 
lower ΔAbs values representing RBC aggregation compared to the positive control (PC) up to 100 
µg/mL. Data are presented as mean ± SD. 
 
Besides hemolysis, RBC aggregation could cause toxic reactions after the systemic injection of 
particles leading to circulatory side effects or toxic reactions. After the mechanical reconstitution 
of the gel, RBC aggregation was investigated regarding the influence of different storage 
conditions (sol or gel) for particles as well as to determine the hemocompatibility of the pure gel 
after liquefaction. Therefore, we investigated the aggregation of isolated erythrocytes after 
incubation with the samples by absorbance measurements at 645 nm and by light microscopy. The 
ΔAbs values were calculated to determine the aggregation quantitatively. Due to the aggregation 
of almost all erythrocytes in clusters (stage 3), the positive control (PC) showed the highest ΔAbs 
value (0.204 ± 0.042) of all samples. The samples themselves did not interact with the absorbance 
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measurement (data not shown). The SiNP-Dex-gel, SiNP-Dex-sol as well as the pure gel showed 
no aggregation up to a concentration of 50 µg/mL (ΔAbs-values < 0.05, Figure 6B). However, at 
a concentration of 100 µg/mL an influence of the dye could be observed. Whereas the RITC as 
well as the FITC-loaded SiNPs-Dex-gel (RITC: ΔAbs = 0.075 ± 0.028, FITC: ΔAbs = 0.042 ± 
0.001) and the pure gel (ΔAbs = 0.058 ± 0.025) caused no RBC aggregation (stage 1) in a 
concentration of 100 µg/mL, SiNP-Dex-sol particles loaded with RITC caused moderate 
aggregations (stage 2-3) accompanied by slightly increased ΔAbs values (ΔAbs = 0.088 ± 0.016). 
Since this was not observed for the FITC-loaded SiNP-Dex-sol (stage 1, ΔAbs = 0.008 ± 0.035) at 
this concentration, this effect could be attributed to the release of the positively charged RITC 
during the storage in solution. Therefore, RITC (pure) was tested for RBC aggregation in similar 
concentrations to confirm the interactions with erythrocytes (data not shown). Due to the fact that 
no differences regarding the aggregation for RITC- or FITC-loaded particles stored in the gel 
(stage 1) were observed by light microscopy, it was indicative of a delayed release of substances 
entrapped into the SiNPs. In conclusion, the gel did not affect the hemocompatibility of the 
particles in vitro. Particles stored in the gel as well as the pure gel did not cause hemolysis or RBC 
aggregation up to a concentration of 100 µg/mL. 
c) HenÕs egg test on the chick area vasculosa ex ovo 
For further investigations regarding the toxicity of the reconstituted gel, the henÕs egg model was 
used as a more complex biological system to evaluate the effect of the NPs and the gel close to the 
situation in vivo. The assessment of the toxicological profile of particles close to the situation in 
vivo is a crucial point in the evaluation of the biocompatibility. Therefore, we used a chicken egg 
based test system in the earliest stages of the development to test the reactions after the systemic 
injection of the SiNP-Dex-sol, SiNP-Dex-gel and the gel (pure) samples in two different 
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concentrations (50 and 125 µg/mL). The HET-CAV offers a vascularized membrane close to the 
situation in vivo (Mller et al., 2015). Changes of the vascularized membrane due to toxic reactions 
(hemorrhage, thrombosis, vascular lysis) or embryonic lethality were investigated after the 
intravenous injection of particles (FITC-loaded) or the gel (pure) for up to 24 hours. The data of 
two independent experiments are represented in Figure 7. The negative control (0.9% sodium 
chloride) as well as the solvent control (DI water) caused negligible hemorrhagic events (1/11 
eggs) that could be related to the injection itself and correlated with the historic lab values 
(hemorrhagic events in 0-1/10 eggs). This is the same for the solvent control, where 1/10 embryo 
died after 24 h as well as the negative control with occasional hemorrhagic effects (0-1/10 eggs) 
and embryonic lethality after 24 h (0-1/10 eggs). In comparison, the injection of the positive 
control (branched PEI 25 kDa, 25 mg/mL in DI water) strongly induced thrombotic events 
(directly after injection) that caused lethality in all eggs (11/11) after 1 h.  
The test samples induced mild and reversible hemorrhagic events after the injection comparable 
to the control groups (1 egg per group). Embryonic lethality occurred occasionally in both 
concentrations of SiNP-Dex-sol (1/10 eggs for 50 µg/mL and 1/12 eggs for 125 µg/mL), in the 
lower concentration of SiNP-Dex-gel (1/10 eggs at 50 µg/mL) and after injection of the higher 
concentration of the gel (1/10 eggs for 125 µg/mL). The slight hemorrhagic effect as well as the 
sporadic appearance of embryonic lethality after 24 h also appeared in the control groups and were 
suggested as non-specific related to the biological variability. Further, these data were comparable 
to our lab historical data as described above. No significant differences regarding the toxicity 
between the test concentrations 50 µg/mL and 125 µg/mL were observed. In conclusion, particles 
stored in gel as well as the pure gel caused no toxic reactions after the systemic injection in the 
chick area vasculosa model. Therefore, the gel and tested particles could be considered as 
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biocompatible in the tested concentrations. In vitro and ex ovo experiments indicated the suitability 
of storing SiNPs within a gel matrix as a non-toxic alternative. 
 
Figure 7 Clustergram showing the time-dependent toxic effects of intravenously applied 
nanoparticles or gel. The columns represent the time after injection of the sample, whereas the 
rows quantify the time-dependent toxic effects. The brightness of the squares is proportional to the 
number of infected eggs. 
Overall, we showed that the NP-gel concept represents a very suitable, non-toxic method for 
storage and manipulation with SiNP. The most significant findings of this study are: i) the 
morphological features and the critical, size-dependent properties of the nanomaterial that can be 
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often lost in solution after few minutes, are preserved in the responsive hydrogel for hours even 
when the particles were exposed to complex cell culture medium during storage; ii) the presented 
method is practical and the nanomaterial stored in the responsive hydrogel made by Fmoc-gal can 
be used in range of biologically relevant applications and tests; iii) the biocompatibility 
experiments indicated that the SiNP sample, including the individual gel components was non-
toxic, despite the presence of gel fibres in the sample and finally, iv) the synthesis of the gelator, 
Fmoc-gal is industrially scalable, which could facilitate the translation of this method from the lab 
to a commercial product. We believe that the presented, proof-of-concept, gel-storage method 
represents a valuable alternative to the existing storage techniques and it will encourage scientists 




Supporting Information. The hydrogel storage concept was animated and it can be seen free of 
charge here: https://www.youtube.com/watch?v=EUQns52Q_q4&feature=em-share_video_user. 
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